What They List
- Psilocybin Clinical Trial
- Study Screening Information
- Research Participation Details
Research
NCT06308653 - Psilocybin for Major Depressive Disorder (MDD)
Clinical Trial in Birmingham, Alabama
Approximately 240 eligible adult participants (>=18 years old) who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for Major Depressive Disorder (MDD) will be enrolled. Participants will be randomly assigned to receive a single oral dose of Psilocybin 25 mg, Psilocybin 5 mg, or inactive placebo. The purpose of this study is to evaluate the efficacy, safety, and tolerability of Psiloc... Source record lists lead sponsor Usona Institute and overall status Active Not Recruiting.
Clinical TrialResearch
Directory Facts
- Status
- Verified from official/source records
- Price
- Free study screening / research participation
- Hours
- Verify with provider
- License / Record
- NCT06308653
- Last Verified
- 2026-06-12
Location
University of Alabama Clinical Research Unit, Birmingham, Alabama
Source Notes
Discovery row generated from the official ClinicalTrials.gov API record for NCT06308653; status Active Not Recruiting; sponsor Usona Institute.
Source: https://clinicaltrials.gov/study/NCT06308653
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.